Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (59,108) $ (21,804)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,892 2,321
Stock-based compensation 2,217 1,259
Change in fair value of warrant liability 56,576  
Expense related to Common Stock warrants issued   124
Amortization (accretion) of discount on investments 406 (22)
Amortization of debt financing cost 4 4
Provision for bad debt 72  
Net increase in accrued interest related to marketable securities (240) (124)
Net unrealized (gain) loss on marketable securities (25)  
Deferred tax benefit (27,921)  
Gain on investment, related to Make Composites, Inc. (1) 159
Change in fair value of warrant liabilities (56,576)  
Changes in operating assets and liabilities:    
Accounts receivable (61) 752
Inventory (2,381) (3,238)
Prepaid expenses and other current assets (4,276) 393
Other assets (30)  
Accounts payable (3,856) (989)
Accrued expenses and other current liabilities (5,247) (976)
Customer deposits (1,234) 285
Deferred revenue 105 (339)
Change in right of use assets and lease liabilities, net (22) (80)
Net cash used in operating activities (41,129) (22,434)
Cash flows from investing activities:    
Purchases of property and equipment (262) (1,004)
Purchase of marketable securities (92,386) (17,616)
Proceeds from sales and maturities of marketable securities 48,241 49,300
Cash paid for acquisition, net of cash acquired (137,646)  
Net cash (used in) provided by investing activities (182,053) 30,680
Cash flows from financing activities:    
Payment of issuance costs related to reverse recapitalization (1,239)  
Proceeds from the exercise of stock warrants 158,308  
Payment of taxes related to net share settlement of upon vesting of restricted stock units (54)  
Proceeds from exercise of stock options 180 132
Net cash provided by financing activities 157,195 132
Net (decrease) increase in cash, cash equivalents, and restricted cash (65,987) 8,378
Effect of exchange rate changes 26  
Cash and cash equivalents at beginning of period 483,525 66,161
Restricted cash 612 612
Cash, cash equivalents, and restricted cash at end of period 418,176 75,151
Supplemental cash flow information:    
Interest paid 73 107
Non-cash investing and financing activities:    
Net unrealized (gain) loss on investments (1) $ 159
Exercise of private placement warrants 149,904  
Common Stock issued for acquisitions 159,847  
Additions to right of use assets and lease liabilities 364  
Purchase of property and equipment included in accounts payable 50  
Receivable for warrants exercised $ 12,357